Related references
Note: Only part of the references are listed.Combined therapy of ruthenium dendrimers and anti-cancer drugs against human leukemic cells
Sylwia Michlewska et al.
DALTON TRANSACTIONS (2021)
Generation Dependent Effects and Entrance to Mitochondria of Hybrid Dendrimers on Normal and Cancer Neuronal Cells In Vitro
Aleksandra Szwed et al.
BIOMOLECULES (2020)
Ruthenium Dendrimers against Human Lymphoblastic Leukemia 1301 Cells
Sylwia Michlewska et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Copper (II) Metallodendrimers Combined with Pro-Apoptotic siRNAs as a Promising Strategy Against Breast Cancer Cells
Natalia Sanz del Olmo et al.
PHARMACEUTICS (2020)
Fine-Tuning the Interaction and Therapeutic Effect of Cu(II) Carbosilane Metallodendrimers in Cancer Cells: An In Vitro Electron Paramagnetic Resonance Study
Barbara Canonico et al.
MOLECULAR PHARMACEUTICS (2020)
Ruthenium dendrimers against acute promyelocytic leukemia: in vitro studies on HL-60 cells
Sylwia Michlewska et al.
FUTURE MEDICINAL CHEMISTRY (2019)
In Vitro Anticancer Properties of Copper Metallodendrimers
Marcin Holota et al.
BIOMOLECULES (2019)
Molecular Mechanisms of Antitumor Activity of PAMAM Dendrimer Conjugates with Anticancer Drugs and a Monoclonal Antibody
Monika Marcinkowska et al.
POLYMERS (2019)
Synthesis and Characterization of FITC Labelled Ruthenium Dendrimer as a Prospective Anticancer Drug
Sylwia Michlewska et al.
BIOMOLECULES (2019)
Exploring the Interactions of Ruthenium (II) Carbosilane Metallodendrimers and Precursors with Model Cell Membranes through a Dual Spin-Label Spin-Probe Technique Using EPR
Riccardo Carloni et al.
BIOMOLECULES (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Insight into the antitumor activity of carbosilane Cu(ii)-metallodendrimers through their interaction with biological membrane models
Natalia Sanz del Olmo et al.
NANOSCALE (2019)
Ruthenium dendrimers as carriers for anticancer siRNA
Sylwia Michlewska et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2018)
First-in-Class Combination Therapy of a Copper(II) Metallo-Phosphorus Dendrimer with Cytotoxic Agents
Serge Mignani et al.
ONCOLOGY (2018)
PAMAM dendrimers as efficient drug and gene delivery nanosystems for cancer therapy
Fereydoon Abedi-Gaballu et al.
APPLIED MATERIALS TODAY (2018)
Nanoparticle-mediated co-delivery of chemotherapeutic agent and siRNA for combination cancer therapy
Bo Xiao et al.
EXPERT OPINION ON DRUG DELIVERY (2017)
Amphiphilic dendritic nanomicelle-mediated co-delivery of 5-fluorouracil and doxorubicin for enhanced therapeutic efficacy
Rui Han et al.
JOURNAL OF DRUG TARGETING (2017)
Ruthenium metallodendrimers with anticancer potential in an acute promyelocytic leukemia cell line (HL60)
Sylwia Michlewska et al.
EUROPEAN POLYMER JOURNAL (2017)
Carbosilane metallodendrimers based on copper (II) complexes: Synthesis, EPR characterization and anticancer activity
Natalia Sanz del Olmo et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2017)
Mitochondria-Targeting Polydopamine Nanoparticles To Deliver Doxorubicin for Overcoming Drug Resistance
Wen-Qing Li et al.
ACS APPLIED MATERIALS & INTERFACES (2017)
Nanoparticle-siRNA: A potential cancer therapy?
Samuel Wang Sherng Young et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2016)
被撤回的出版物: Low density lipoprotein receptor targeted doxorubicin/DNA-Gold Nanorods as a chemo- and thermo-dual therapy for prostate cancer (Retracted article. See vol. 616, 2022)
Nan Zhang et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2016)
5-FU targets rpL3 to induce mitochondrial apoptosis via cystathionine-β-synthase in colon cancer cells lacking p53
Valentina Pagliara et al.
ONCOTARGET (2016)
Mechanisms and Implications of Dual-Acting Methotrexate in Folate-Targeted Nanotherapeutic Delivery
Pamela T. Wong et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
Anticancer siRNA cocktails as a novel tool to treat cancer cells. Part (A). Mechanisms of interaction
Maksim Ionov et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2015)
Interference of cationic polymeric nanoparticles with clinical chemistry tests-Clinical relevance
Dzmitry Shcharbin et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2014)
Emerging concepts in dendrimer-based nanomedicine: from design principles to clinical applications
R. M. Kannan et al.
JOURNAL OF INTERNAL MEDICINE (2014)
A systematic review of the pathophysiology of 5-fluorouracil-induced cardiotoxicity
Anne Polk et al.
BMC PHARMACOLOGY & TOXICOLOGY (2014)
Effect of methotrexate conjugated PAMAM dendrimers on the viability of MES-SA uterine cancer cells
Samreen Khatri et al.
JOURNAL OF PHARMACY AND BIOALLIED SCIENCES (2014)
A 5-fluorouracil-loaded pH-responsive dendrimer nanocarrier for tumor targeting
Yiguang Jin et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2011)
Dendrimers as versatile platform in drug delivery applications
Sonke Svenson
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2009)
The effect of surface functionality on cellular trafficking of dendrimers
Omathanu P. Perumal et al.
BIOMATERIALS (2008)
Therapeutic nanoparticles for drug delivery in cancer
Kwangjae Cho et al.
CLINICAL CANCER RESEARCH (2008)
Pharmaceutical applications of dendrimers: promising nanocarriers for drug delivery
Yiyun Cheng et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
Mitochondrial ROS-induced ROS release: An update and review
Dmitry B. Zorov et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2006)
Regulation of Bcl-2 proteins and of the permeability of the outer mitochondrial membrane
S Lucken-Ardjomande et al.
COMPTES RENDUS BIOLOGIES (2005)
Serum and tissue trace elements in patients with breast cancer in Taiwan
HW Kuo et al.
BIOLOGICAL TRACE ELEMENT RESEARCH (2002)
ROS, stress-activated kinases and stress signaling in cancer
M Benhar et al.
EMBO REPORTS (2002)
Analysis of serum copper and zinc concentrations in cancer patients
M Zowczak et al.
BIOLOGICAL TRACE ELEMENT RESEARCH (2001)
Role of reactive oxygen species (ROS) in apoptosis induction
HU Simon et al.
APOPTOSIS (2000)
Share Paper
